{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T19:34:48Z","timestamp":1781811288623,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:00:00Z","timestamp":1724371200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:00:00Z","timestamp":1724371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thrombosis J"],"DOI":"10.1186\/s12959-024-00641-4","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T19:45:58Z","timestamp":1724442358000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Coagulation dysfunction events associated with echinocandins: a real-world study from FDA adverse event reporting system (FAERS) database"],"prefix":"10.1186","volume":"22","author":[{"given":"Qian","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengling","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shupeng","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,23]]},"reference":[{"issue":"11","key":"641_CR1","doi-asserted-by":"publisher","first-page":"6872","DOI":"10.1128\/aac.00701-16","volume":"60","author":"V Ong","year":"2016","unstructured":"Ong V, Hough G, Schlosser M, et al. Preclinical evaluation of the Stability, Safety, and efficacy of CD101, a Novel Echinocandin. Antimicrob Agents Chemother Nov. 2016;60(11):6872\u20139. https:\/\/doi.org\/10.1128\/aac.00701-16.","journal-title":"Antimicrob Agents Chemother Nov"},{"issue":"1","key":"641_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2147\/tcrm.2007.3.1.71","volume":"3","author":"G Eschenauer","year":"2007","unstructured":"Eschenauer G, Depestel DD, Carver PL. Comparison of echinocandin antifungals. Ther Clin Risk Manag Mar. 2007;3(1):71\u201397. https:\/\/doi.org\/10.2147\/tcrm.2007.3.1.71.","journal-title":"Ther Clin Risk Manag Mar"},{"issue":"1","key":"641_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1586\/14787210.5.1.45","volume":"5","author":"P de la Torre","year":"2007","unstructured":"de la Torre P, Reboli AC. Anidulafungin: a new echinocandin for candidal infections. Expert Rev Anti Infect Ther Feb. 2007;5(1):45\u201352. https:\/\/doi.org\/10.1586\/14787210.5.1.45.","journal-title":"Expert Rev Anti Infect Ther Feb"},{"key":"641_CR4","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2147\/dddt.s3242","volume":"29","author":"AM Bormann","year":"2009","unstructured":"Bormann AM, Morrison VA. Review of the pharmacology and clinical studies of micafungin. Drug Des Devel Ther Dec. 2009;29:3:295\u2013302. https:\/\/doi.org\/10.2147\/dddt.s3242.","journal-title":"Drug Des Devel Ther Dec"},{"issue":"1","key":"641_CR5","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1080\/14756366.2022.2050224","volume":"37","author":"M Szyma\u0144ski","year":"2022","unstructured":"Szyma\u0144ski M, Chmielewska S, Czy\u017cewska U, Malinowska M, Tylicki A. Echinocandins - structure, mechanism of action and use in antifungal therapy. J Enzyme Inhib Med Chem Dec. 2022;37(1):876\u201394. https:\/\/doi.org\/10.1080\/14756366.2022.2050224.","journal-title":"J Enzyme Inhib Med Chem Dec"},{"issue":"1","key":"641_CR6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2147\/tcrm.2007.3.1.71","volume":"3","author":"G Eschenauer","year":"2007","unstructured":"Eschenauer G, Depestel DD, Carver PL. Comparison of echinocandin antifungals. Ther Clin Risk Manag. 2007;3(1):71\u201397.","journal-title":"Ther Clin Risk Manag"},{"issue":"17","key":"641_CR7","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1056\/nejm198710223171717","volume":"22","author":"RD Mosteller","year":"1987","unstructured":"Mosteller RD. Simplified calculation of body-surface area. N Engl J Med Oct. 1987;22(17):1098. https:\/\/doi.org\/10.1056\/nejm198710223171717.","journal-title":"N Engl J Med Oct"},{"issue":"9","key":"641_CR8","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1086\/323401","volume":"1","author":"A Villanueva","year":"2001","unstructured":"Villanueva A, Arathoon EG, Gotuzzo E, Berman RS, DiNubile MJ, Sable CA. A randomized double-blind study of caspofungin versus amphotericin for the treatment of candidal esophagitis. Clin Infect Dis Nov. 2001;1(9):1529\u201335. https:\/\/doi.org\/10.1086\/323401.","journal-title":"Clin Infect Dis Nov"},{"issue":"4","key":"641_CR9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/inf.0000000000002568","volume":"39","author":"E Roilides","year":"2020","unstructured":"Roilides E, Carlesse F, Tawadrous M, et al. Safety, Efficacy and Pharmacokinetics of Anidulafungin in patients 1 Month to <\u20092 years of Age with Invasive Candidiasis, including Candidemia. Pediatr Infect Dis J Apr. 2020;39(4):305\u20139. https:\/\/doi.org\/10.1097\/inf.0000000000002568.","journal-title":"Pediatr Infect Dis J Apr"},{"issue":"10","key":"641_CR10","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1097\/inf.0000000000001996","volume":"37","author":"DK Benjamin","year":"2018","unstructured":"Benjamin DK Jr., Kaufman DA, Hope WW, et al. A phase 3 study of Micafungin Versus Amphotericin B Deoxycholate in infants with Invasive Candidiasis. Pediatr Infect Dis J Oct. 2018;37(10):992\u20138. https:\/\/doi.org\/10.1097\/inf.0000000000001996.","journal-title":"Pediatr Infect Dis J Oct"},{"issue":"10370","key":"641_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/s0140-6736(22)02324-8","volume":"7","author":"GR Thompson","year":"2023","unstructured":"Thompson GR 3rd, Soriano A, Cornely OA, et al. Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial. Lancet Jan. 2023;7(10370):49\u201359. https:\/\/doi.org\/10.1016\/s0140-6736(22)02324-8.","journal-title":"Lancet Jan"},{"issue":"6","key":"641_CR12","doi-asserted-by":"publisher","first-page":"e258","DOI":"10.1097\/MJT.0b013e3181d5e401","volume":"18","author":"M Nazzal","year":"2011","unstructured":"Nazzal M, Safi F, Arma F, Nazzal M, Muzaffar M, Assaly R. Micafungin-induced thrombotic thrombocytopenic purpura: a case report and review of the literature. Am J Ther Nov. 2011;18(6):e258\u201360. https:\/\/doi.org\/10.1097\/MJT.0b013e3181d5e401.","journal-title":"Am J Ther Nov"},{"issue":"6","key":"641_CR13","doi-asserted-by":"publisher","first-page":"C1553","DOI":"10.1152\/ajpcell.00186.2003","volume":"285","author":"PA Lang","year":"2003","unstructured":"Lang PA, Kaiser S, Myssina S, Wieder T, Lang F, Huber SM. Role of Ca2+-activated K\u2009+\u2009channels in human erythrocyte apoptosis. Am J Physiol Cell Physiol Dec. 2003;285(6):C1553\u201360. https:\/\/doi.org\/10.1152\/ajpcell.00186.2003.","journal-title":"Am J Physiol Cell Physiol Dec"},{"key":"641_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.semcdb.2015.01.009","volume":"39","author":"E Lang","year":"2015","unstructured":"Lang E, Lang F. Mechanisms and pathophysiological significance of eryptosis, the suicidal erythrocyte death. Semin Cell Dev Biol Mar. 2015;39:35\u201342. https:\/\/doi.org\/10.1016\/j.semcdb.2015.01.009.","journal-title":"Semin Cell Dev Biol Mar"},{"issue":"2","key":"641_CR15","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1159\/000445650","volume":"39","author":"T Peter","year":"2016","unstructured":"Peter T, Bissinger R, Signoretto E, Mack AF, Lang F. Micafungin-Induced suicidal erythrocyte death. Cell Physiol Biochem. 2016;39(2):584\u201395. https:\/\/doi.org\/10.1159\/000445650.","journal-title":"Cell Physiol Biochem"},{"issue":"2","key":"641_CR16","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1053\/beha.2001.0142","volume":"14","author":"M Furlan","year":"2001","unstructured":"Furlan M, L\u00e4mmle B. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of Von Willebrand factor-cleaving protease. Best Pract Res Clin Haematol Jun. 2001;14(2):437\u201354. https:\/\/doi.org\/10.1053\/beha.2001.0142.","journal-title":"Best Pract Res Clin Haematol Jun"},{"issue":"52","key":"641_CR17","doi-asserted-by":"publisher","first-page":"e9443","DOI":"10.1097\/md.0000000000009443","volume":"96","author":"Y Ji","year":"2017","unstructured":"Ji Y, Song Y, Zhou F, et al. Efficacy and safety of micafungin for the treatment of patients with proven or probable invasive aspergillosis: a non-comparative, multicenter, phase IV, open-label study. Med (Baltimore) Dec. 2017;96(52):e9443. https:\/\/doi.org\/10.1097\/md.0000000000009443.","journal-title":"Med (Baltimore) Dec"},{"issue":"9","key":"641_CR18","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.2169\/internalmedicine.50.4303","volume":"50","author":"M Yoshida-Hiroi","year":"2011","unstructured":"Yoshida-Hiroi M, Koizumi M, Oka R, Mitsuda A, Hiroi N. First case report of acquired pure red cell aplasia associated with micafungin. Intern Med. 2011;50(9):1051\u20134. https:\/\/doi.org\/10.2169\/internalmedicine.50.4303.","journal-title":"Intern Med"},{"issue":"5","key":"641_CR19","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1182\/blood.V30.5.587.587","volume":"30","author":"AA Yunis","year":"1967","unstructured":"Yunis AA, Arimura GK, Lutcher CL, Blasquez J, Halloran M. Biochemical lesion in Dilantin-induced erythroid aplasia. Blood Nov. 1967;30(5):587\u2013600.","journal-title":"Blood Nov"},{"key":"641_CR20","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.ijid.2022.07.023","volume":"122","author":"H Ishii","year":"2022","unstructured":"Ishii H, Sato T, Ishibashi M, et al. A case of immune complex type hemolytic anemia induced by initial micafungin administration. Int J Infect Dis Sep. 2022;122:755\u20137. https:\/\/doi.org\/10.1016\/j.ijid.2022.07.023.","journal-title":"Int J Infect Dis Sep"},{"issue":"4\u20135","key":"641_CR21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.blre.2010.06.004","volume":"24","author":"G Garratty","year":"2010","unstructured":"Garratty G. Immune hemolytic anemia associated with drug therapy. Blood Rev Jul-Sep. 2010;24(4\u20135):143\u201350. https:\/\/doi.org\/10.1016\/j.blre.2010.06.004.","journal-title":"Blood Rev Jul-Sep"},{"issue":"1","key":"641_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1034\/j.1399-3062.2002.01004.x","volume":"4","author":"CA Sable","year":"2002","unstructured":"Sable CA, Nguyen BY, Chodakewitz JA, DiNubile MJ. Safety and tolerability of caspofungin acetate in the treatment of fungal infections. Transpl Infect Dis Mar. 2002;4(1):25\u201330. https:\/\/doi.org\/10.1034\/j.1399-3062.2002.01004.x.","journal-title":"Transpl Infect Dis Mar"},{"issue":"10","key":"641_CR23","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1592\/phco.24.14.1408.43148","volume":"24","author":"J Lynch","year":"2004","unstructured":"Lynch J, Wong-Beringer A. Caspofungin: a potential cause of reversible severe thrombocytopenia. Pharmacotherapy Oct. 2004;24(10):1408\u201311. https:\/\/doi.org\/10.1592\/phco.24.14.1408.43148.","journal-title":"Pharmacotherapy Oct"},{"issue":"3","key":"641_CR24","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s15010-023-02162-0","volume":"52","author":"SD Yuan","year":"2024","unstructured":"Yuan SD, Wen KL, Cao YX, Huang WQ, Zhang A. Safety and efficacy of non-reduced use of caspofungin in patients with child-pugh B or C cirrhosis: a real-world study. Infect Jun. 2024;52(3):1063\u201372. https:\/\/doi.org\/10.1007\/s15010-023-02162-0.","journal-title":"Infect Jun"},{"issue":"1","key":"641_CR25","doi-asserted-by":"publisher","first-page":"110","DOI":"10.7182\/pit2012329","volume":"22","author":"S K\u00f6se","year":"2012","unstructured":"K\u00f6se S, T\u00fcrken M, Akko\u00e7lu G, Karaca C, Senger SS. Disseminated candidiasis developing during prophylaxis with fluconazole in a small-intestine transplant recipient. Prog Transpl Mar. 2012;22(1):110\u20132. https:\/\/doi.org\/10.7182\/pit2012329.","journal-title":"Prog Transpl Mar"},{"issue":"6","key":"641_CR26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.curtheres.2012.07.002","volume":"73","author":"C Chen","year":"2012","unstructured":"Chen C, Guo DH, Cao X, et al. Risk factors for thrombocytopenia in adult Chinese patients receiving linezolid therapy. Curr Ther Res Clin Exp Dec. 2012;73(6):195\u2013206. https:\/\/doi.org\/10.1016\/j.curtheres.2012.07.002.","journal-title":"Curr Ther Res Clin Exp Dec"},{"key":"641_CR27","doi-asserted-by":"publisher","first-page":"6145","DOI":"10.2147\/idr.S408102","volume":"16","author":"L Zhang","year":"2023","unstructured":"Zhang L, Yan Y, Liao R, Dong H. Effect of platelet parameters on Linezolid-related Thrombocytopenia in Hospitalized patients. Infect Drug Resist. 2023;16:6145\u201354. https:\/\/doi.org\/10.2147\/idr.S408102.","journal-title":"Infect Drug Resist"},{"issue":"1","key":"641_CR28","first-page":"85","volume":"1","author":"B Ceylan","year":"2019","unstructured":"Ceylan B, Yilmaz M, Bek\u00f6z HS, Ramadan S, Ertan Akan G, Mert A. Primary gastrointestinal aspergillosis: a case report and literature review. Infez Med Mar. 2019;1(1):85\u201392.","journal-title":"Infez Med Mar"},{"issue":"3","key":"641_CR29","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/inf.0000000000002237","volume":"38","author":"E Roilides","year":"2019","unstructured":"Roilides E, Carlesse F, Leister-Tebbe H, et al. A prospective, open-label study to assess the Safety, Tolerability and Efficacy of Anidulafungin in the Treatment of Invasive Candidiasis in Children 2 to <\u200918 years of age. Pediatr Infect Dis J Mar. 2019;38(3):275\u20139. https:\/\/doi.org\/10.1097\/inf.0000000000002237.","journal-title":"Pediatr Infect Dis J Mar"},{"key":"641_CR30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jgar.2019.01.029","volume":"18","author":"CZ Hua","year":"2019","unstructured":"Hua CZ, Wang HJ, Zhang Z, et al. In vitro activity and clinical efficacy of macrolides, cefoperazone-sulbactam and piperacillin\/piperacillin-tazobactam against Bordetella pertussis and the clinical manifestations in pertussis patients due to these isolates: a single-centre study in Zhejiang Province, China. J Glob Antimicrob Resist Sep. 2019;18:47\u201351. https:\/\/doi.org\/10.1016\/j.jgar.2019.01.029.","journal-title":"J Glob Antimicrob Resist Sep"},{"issue":"1","key":"641_CR31","first-page":"161","volume":"33","author":"Y Li","year":"2020","unstructured":"Li Y, Xie J, Chen L, et al. Treatment efficacy of tigecycline in comparison to cefoperazone\/ sulbactam alone or in combination therapy for carbapenenm-resistant Acinetobacter baumannii infections. Pak J Pharm Sci Jan. 2020;33(1):161\u20138.","journal-title":"Pak J Pharm Sci Jan"},{"issue":"3","key":"641_CR32","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1128\/aac.04305-14","volume":"59","author":"Q Zhang","year":"2015","unstructured":"Zhang Q, Zhou S, Zhou J. Tigecycline treatment causes a decrease in fibrinogen levels. Antimicrob Agents Chemother Mar. 2015;59(3):1650\u20135. https:\/\/doi.org\/10.1128\/aac.04305-14.","journal-title":"Antimicrob Agents Chemother Mar"},{"issue":"10","key":"641_CR33","first-page":"1973","volume":"285","author":"L Stephen","year":"2001","unstructured":"Stephen L. Green. Linezolid and reversible myelosuppression. JAMA. 2001;285(10):1973\u20134.","journal-title":"JAMA"},{"issue":"1","key":"641_CR34","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ijantimicag.2010.10.001","volume":"37","author":"D Pascoalinho","year":"2011","unstructured":"Pascoalinho D, Vilas MJ, Coelho L, Moreira P. Linezolid-related immune-mediated severe thrombocytopenia. Int J Antimicrob Agents Jan. 2011;37(1):88\u20139. https:\/\/doi.org\/10.1016\/j.ijantimicag.2010.10.001.","journal-title":"Int J Antimicrob Agents Jan"},{"issue":"3","key":"641_CR35","first-page":"300","volume":"40","author":"SY Kim","year":"2010","unstructured":"Kim SY, Cho SY, Lee HJ, et al. Superwarfarin intoxication of unknown etiology accompanying hemoperitoneum in a patient on fluconazole therapy. Ann Clin Lab Sci Summer. 2010;40(3):300\u20133.","journal-title":"Ann Clin Lab Sci Summer"},{"issue":"8","key":"641_CR36","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/ajhp\/zxad021","volume":"8","author":"YS Alsowaida","year":"2023","unstructured":"Alsowaida YS, Alamer A, Thabit AK, et al. Echinocandin exposures in obese patients: a scoping review and clinical perspectives. Am J Health Syst Pharm Apr. 2023;8(8):503\u201317. https:\/\/doi.org\/10.1093\/ajhp\/zxad021.","journal-title":"Am J Health Syst Pharm Apr"},{"issue":"7","key":"641_CR37","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.soard.2019.03.048","volume":"15","author":"J Samuels","year":"2019","unstructured":"Samuels J, Lawson PJ, Morton AP, et al. Prospective assessment of fibrinolysis in morbid obesity: tissue plasminogen activator resistance improves after bariatric surgery. Surg Obes Relat Dis Jul. 2019;15(7):1153\u20139. https:\/\/doi.org\/10.1016\/j.soard.2019.03.048.","journal-title":"Surg Obes Relat Dis Jul"},{"issue":"10","key":"641_CR38","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/bf03344054","volume":"25","author":"G De Pergola","year":"2002","unstructured":"De Pergola G, Pannacciulli N. Coagulation and fibrinolysis abnormalities in obesity. J Endocrinol Invest Nov. 2002;25(10):899\u2013904. https:\/\/doi.org\/10.1007\/bf03344054.","journal-title":"J Endocrinol Invest Nov"}],"container-title":["Thrombosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-024-00641-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12959-024-00641-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-024-00641-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T11:18:30Z","timestamp":1771327110000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12959-024-00641-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,23]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["641"],"URL":"https:\/\/doi.org\/10.1186\/s12959-024-00641-4","relation":{},"ISSN":["1477-9560"],"issn-type":[{"value":"1477-9560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,23]]},"assertion":[{"value":"13 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"78"}}